Literature DB >> 7512154

Isoprenylation masks a conformational epitope and enhances trans-dominant inhibitory function of the large hepatitis delta antigen.

S B Hwang1, M M Lai.   

Abstract

Hepatitis delta antigen (HDAg) consists of two species, large (LHDAg) and small (SHDAg), which are identical in sequence except that the large form contains 19 extra amino acids at the C terminus. The large form is prenylated on the Cxxx motif. The small form can trans activate HDV RNA replication, while the large form inhibits it. To determine the molecular basis for their differential functions, we examined the effects of prenylation on the conformation and function of HDAg. We show that the presence of prenylates masks a conformational epitope which is present in SHDAg but hidden in wild-type LHDAg; this epitope becomes exposed in all of the nonprenylated mutant LHDAgs. Prenylation also plays a major role in conferring the trans-dominant negative inhibitory activity of LHDAg, since the loss of prenylation in LHDAg reduced its inhibitory activity. The primary amino acids of the C-terminal sequence also contributed to the maintenance of the HDAg protein conformation; a prenylated LHDAg mutant with a five-amino-acid deletion had an exposed C-terminal epitope. By examining LHDAg mutants which have deletions of various extents of C-terminal sequence, with or without the prenylation motif, we have further shown that all of the prenylated mutants have much higher levels of trans-dominant suppressor activities than do the corresponding nonprenylated mutants. Surprisingly, a few nonprenylated LHDAg mutants were able to trans activate HDV RNA replication, while all of the prenylated ones lost this function. These results suggest that isoprenylates cause the masking of a conformational epitope of HDAg and that conformational differences between the large and small HDAgs account for the differences in their trans-activating and trans-dominant inhibitory biological activities.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7512154      PMCID: PMC236784     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

1.  A polybasic domain or palmitoylation is required in addition to the CAAX motif to localize p21ras to the plasma membrane.

Authors:  J F Hancock; H Paterson; C J Marshall
Journal:  Cell       Date:  1990-10-05       Impact factor: 41.582

2.  Initiation of replication of the human hepatitis delta virus genome from cloned DNA: role of delta antigen.

Authors:  M Y Kuo; M Chao; J Taylor
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

3.  A specific base transition occurs on replicating hepatitis delta virus RNA.

Authors:  G X Luo; M Chao; S Y Hsieh; C Sureau; K Nishikura; J Taylor
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

4.  The CaaX motif of lamin A functions in conjunction with the nuclear localization signal to target assembly to the nuclear envelope.

Authors:  D Holtz; R A Tanaka; J Hartwig; F McKeon
Journal:  Cell       Date:  1989-12-22       Impact factor: 41.582

5.  Reversible cleavage and ligation of hepatitis delta virus RNA.

Authors:  H N Wu; M M Lai
Journal:  Science       Date:  1989-02-03       Impact factor: 47.728

6.  Self-ligating RNA sequences on the antigenome of human hepatitis delta virus.

Authors:  L Sharmeen; M Y Kuo; J Taylor
Journal:  J Virol       Date:  1989-03       Impact factor: 5.103

7.  Role of two forms of hepatitis delta virus antigen: evidence for a mechanism of self-limiting genome replication.

Authors:  M Chao; S Y Hsieh; J Taylor
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

8.  Hepatitis delta virus RNA, protein synthesis and associated cytotoxicity in a stably transfected cell line.

Authors:  T B Macnaughton; E J Gowans; A R Jilbert; C J Burrell
Journal:  Virology       Date:  1990-08       Impact factor: 3.616

9.  The membrane binding domain of rod cGMP phosphodiesterase is posttranslationally modified by methyl esterification at a C-terminal cysteine.

Authors:  O C Ong; I M Ota; S Clarke; B K Fung
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

10.  Human hepatitis delta virus RNA subfragments contain an autocleavage activity.

Authors:  H N Wu; Y J Lin; F P Lin; S Makino; M F Chang; M M Lai
Journal:  Proc Natl Acad Sci U S A       Date:  1989-03       Impact factor: 11.205

View more
  24 in total

1.  Unique properties of the large antigen of hepatitis delta virus.

Authors:  G Moraleda; S Seeholzer; V Bichko; R Dunbrack; J Otto; J Taylor
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

2.  By inhibiting replication, the large hepatitis delta antigen can indirectly regulate amber/W editing and its own expression.

Authors:  Shuji Sato; Cromwell Cornillez-Ty; David W Lazinski
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

3.  Hepatitis delta virus antigen is methylated at arginine residues, and methylation regulates subcellular localization and RNA replication.

Authors:  Yi-Jia Li; Michael R Stallcup; Michael M C Lai
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

4.  Roles of carboxyl-terminal and farnesylated residues in the functions of the large hepatitis delta antigen.

Authors:  Brendan O'Malley; David W Lazinski
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

Review 5.  RNA replication without RNA-dependent RNA polymerase: surprises from hepatitis delta virus.

Authors:  Michael M C Lai
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

6.  Molecular and clinical aspects of hepatitis D virus infections.

Authors:  Elham Shirvani Dastgerdi; Ulf Herbers; Frank Tacke
Journal:  World J Virol       Date:  2012-06-12

7.  The large delta antigen of hepatitis delta virus potently inhibits genomic but not antigenomic RNA synthesis: a mechanism enabling initiation of viral replication.

Authors:  L E Modahl; M M Lai
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

8.  Characterization of the phosphorylated forms and the phosphorylated residues of hepatitis delta virus delta antigens.

Authors:  J J Mu; H L Wu; B L Chiang; R P Chang; D S Chen; P J Chen
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

Review 9.  Hepatitis delta virus: insights into a peculiar pathogen and novel treatment options.

Authors:  Florian A Lempp; Yi Ni; Stephan Urban
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-08-18       Impact factor: 46.802

10.  Activation of heterologous gene expression by the large isoform of hepatitis delta antigen.

Authors:  Y Wei; D Ganem
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.